Survival rates for lung cancer may have fallen by 2% due to delays in diagnosis caused by the COVID-19 pandemic Published on 13/09/2021 Madrid, September 13, 2021- "the survival rate in lung cancer in Spain may have fallen by 2% since the beginning of the pandemic as a result of delays in diagnosing patients”, as stated by Dr. Allan Sam, head of the Pulmonology Service at MD Anderson Cancer Center Madrid – Hospiten, on the occasion of European Lung Cancer Week, which takes place these days, who also adds that the real figure will not be known until after a year or two.
MD Anderson Madrid – Hospiten presta atención sanitaria a los pacientes oncológicos de la Comunidad de Madrid Published on 24/03/2020 Debido a la especial protección que requieren estos pacientes y a su mayor riesgo potencial en caso de infección por coronavirus, el centro está acogiendo pacientes oncológicos de otros hospitales de la Comunidad de Madrid, en el marco del estado de alarma decretado en España por la pandemia por COVID-19